Exact Mass: 510.2465
Exact Mass Matches: 510.2465
Found 500 metabolites which its exact mass value is equals to given mass value 510.2465
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Physagulin A
Physagulin A is found in fruits. Physagulin A is a constituent of the famine food Physalis angulata (cutleaf ground cherry).
Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-
PA(2:0/18:1(12Z)-2OH(9,10))
PA(2:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(12Z)-2OH(9,10)/2:0)
PA(18:1(12Z)-2OH(9,10)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/2:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Schweinfurthin H
A stilbenoid isolated from Macaranga alnifolia and has been shwon to exhibit cytotoxic activity.
ent-6,9-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyranosyl ester
2alpha,16-dihydroxy-4beta-carboxy-O-beta-D-glucopyranosyl-19-nor-totarol
4beta,9alpha,20-trihydroxy-13,15-secotiglia-1,6-diene-3,13-dione 20-O-beta-D-glucopyranoside|euphopiloside A|[(3aR,6aS,7S,10R,10aR,10bS)-3,3a,4,6a,7,8,9,10,10a,10b-decahydro-3a,10a-dihydroxy-2,10-dimethyl-3,8-dioxo-7-(propan-2-yl)benzo[e]azulen-5-yl]methyl beta-D-glucopyranoside
5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene
(4aR,5R,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-6-(hydroxymethyl)-5,8a-dimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|17-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone 18-beta-D-glucopyranosyl ester|caseariaside B
(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A
Ile Thr Tyr Asp
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based: Match]
Ala Phe His His
Ala His Phe His
Ala His His Phe
Cys Ile Ile Tyr
Cys Ile Leu Tyr
Cys Ile Tyr Ile
Cys Ile Tyr Leu
Cys Leu Ile Tyr
Cys Leu Leu Tyr
Cys Leu Tyr Ile
Cys Leu Tyr Leu
Cys Tyr Ile Ile
Cys Tyr Ile Leu
Cys Tyr Leu Ile
Cys Tyr Leu Leu
Asp Ile Thr Tyr
Asp Ile Tyr Thr
Asp Leu Thr Tyr
Asp Leu Tyr Thr
Asp Thr Ile Tyr
Asp Thr Leu Tyr
Asp Thr Tyr Ile
Asp Thr Tyr Leu
Asp Tyr Ile Thr
Asp Tyr Leu Thr
Asp Tyr Thr Ile
Asp Tyr Thr Leu
Glu Ile Ser Tyr
Glu Ile Tyr Ser
Glu Leu Ser Tyr
Glu Leu Tyr Ser
Glu Ser Ile Tyr
Glu Ser Leu Tyr
Glu Ser Tyr Ile
Glu Ser Tyr Leu
Glu Thr Val Tyr
Glu Thr Tyr Val
Glu Val Thr Tyr
Glu Val Tyr Thr
Glu Tyr Ile Ser
Glu Tyr Leu Ser
Glu Tyr Ser Ile
Glu Tyr Ser Leu
Glu Tyr Thr Val
Glu Tyr Val Thr
Phe Ala His His
Phe Phe Pro Thr
Phe Phe Thr Pro
Phe His Ala His
Phe His His Ala
Phe Ile Met Thr
Phe Ile Thr Met
Phe Leu Met Thr
Phe Leu Thr Met
Phe Met Ile Thr
Phe Met Leu Thr
Phe Met Thr Ile
Phe Met Thr Leu
Phe Pro Phe Thr
Phe Pro Thr Phe
Phe Thr Phe Pro
Phe Thr Ile Met
Phe Thr Leu Met
Phe Thr Met Ile
Phe Thr Met Leu
Phe Thr Pro Phe
His Ala Phe His
His Ala His Phe
His Phe Ala His
His Phe His Ala
His His Ala Phe
His His Phe Ala
His Ile Asn Gln
His Ile Gln Asn
His Leu Asn Gln
His Leu Gln Asn
His Asn Ile Gln
His Asn Leu Gln
His Asn Gln Ile
His Asn Gln Leu
His Gln Ile Asn
His Gln Leu Asn
His Gln Asn Ile
His Gln Asn Leu
His Gln Gln Val
His Gln Val Gln
His Val Gln Gln
Ile Cys Ile Tyr
Ile Cys Leu Tyr
Ile Cys Tyr Ile
Ile Cys Tyr Leu
Ile Asp Thr Tyr
Ile Asp Tyr Thr
Ile Glu Ser Tyr
Ile Glu Tyr Ser
Ile Phe Met Thr
Ile Phe Thr Met
Ile His Asn Gln
Ile His Gln Asn
Ile Ile Cys Tyr
Ile Ile Tyr Cys
Ile Leu Cys Tyr
Ile Leu Tyr Cys
Ile Met Phe Thr
Ile Met Thr Phe
Ile Asn His Gln
Ile Asn Gln His
Ile Gln His Asn
Ile Gln Asn His
Ile Ser Glu Tyr
Ile Ser Tyr Glu
Ile Thr Asp Tyr
Ile Thr Phe Met
Ile Thr Met Phe
Ile Tyr Cys Ile
Ile Tyr Cys Leu
Ile Tyr Asp Thr
Ile Tyr Glu Ser
Ile Tyr Ile Cys
Ile Tyr Leu Cys
Ile Tyr Ser Glu
Ile Tyr Thr Asp
Lys Asn Ser Tyr
Lys Asn Tyr Ser
Lys Ser Asn Tyr
Lys Ser Tyr Asn
Lys Tyr Asn Ser
Lys Tyr Ser Asn
Leu Cys Ile Tyr
Leu Cys Leu Tyr
Leu Cys Tyr Ile
Leu Cys Tyr Leu
Leu Asp Thr Tyr
Leu Asp Tyr Thr
Leu Glu Ser Tyr
Leu Glu Tyr Ser
Leu Phe Met Thr
Leu Phe Thr Met
Leu His Asn Gln
Leu His Gln Asn
Leu Ile Cys Tyr
Leu Ile Tyr Cys
Leu Leu Cys Tyr
Leu Leu Tyr Cys
Leu Met Phe Thr
Leu Met Thr Phe
Leu Asn His Gln
Leu Asn Gln His
Leu Gln His Asn
Leu Gln Asn His
Leu Ser Glu Tyr
Leu Ser Tyr Glu
Leu Thr Asp Tyr
Leu Thr Phe Met
Leu Thr Met Phe
Leu Thr Tyr Asp
Leu Tyr Cys Ile
Leu Tyr Cys Leu
Leu Tyr Asp Thr
Leu Tyr Glu Ser
Leu Tyr Ile Cys
Leu Tyr Leu Cys
Leu Tyr Ser Glu
Leu Tyr Thr Asp
Met Phe Ile Thr
Met Phe Leu Thr
Met Phe Thr Ile
Met Phe Thr Leu
Met Ile Phe Thr
Met Ile Thr Phe
Met Leu Phe Thr
Met Leu Thr Phe
Met Thr Phe Ile
Met Thr Phe Leu
Met Thr Ile Phe
Met Thr Leu Phe
Met Val Val Tyr
Met Val Tyr Val
Met Tyr Val Val
Asn His Ile Gln
Asn His Leu Gln
Asn His Gln Ile
Asn His Gln Leu
Asn Ile His Gln
Asn Ile Gln His
Asn Lys Ser Tyr
Asn Lys Tyr Ser
Asn Leu His Gln
Asn Leu Gln His
Asn Gln His Ile
Asn Gln His Leu
Asn Gln Ile His
Asn Gln Leu His
Asn Ser Lys Tyr
Asn Ser Tyr Lys
Asn Tyr Lys Ser
Asn Tyr Ser Lys
Pro Phe Phe Thr
Pro Phe Thr Phe
Pro Thr Phe Phe
Gln His Ile Asn
Gln His Leu Asn
Gln His Asn Ile
Gln His Asn Leu
Gln His Gln Val
Gln His Val Gln
Gln Ile His Asn
Gln Ile Asn His
Gln Leu His Asn
Gln Leu Asn His
Gln Asn His Ile
Gln Asn His Leu
Gln Asn Ile His
Gln Asn Leu His
Gln Gln His Val
Gln Gln Val His
Gln Val His Gln
Gln Val Gln His
Ser Glu Ile Tyr
Ser Glu Leu Tyr
Ser Glu Tyr Ile
Ser Glu Tyr Leu
Ser Ile Glu Tyr
Ser Ile Tyr Glu
Ser Lys Asn Tyr
Ser Lys Tyr Asn
Ser Leu Glu Tyr
Ser Leu Tyr Glu
Ser Asn Lys Tyr
Ser Asn Tyr Lys
Ser Tyr Glu Ile
Ser Tyr Glu Leu
Ser Tyr Ile Glu
Ser Tyr Lys Asn
Ser Tyr Leu Glu
Ser Tyr Asn Lys
Thr Asp Ile Tyr
Thr Asp Leu Tyr
Thr Asp Tyr Ile
Thr Asp Tyr Leu
Thr Glu Val Tyr
Thr Glu Tyr Val
Thr Phe Phe Pro
Thr Phe Ile Met
Thr Phe Leu Met
Thr Phe Met Ile
Thr Phe Met Leu
Thr Phe Pro Phe
Thr Ile Asp Tyr
Thr Ile Phe Met
Thr Ile Met Phe
Thr Ile Tyr Asp
Thr Leu Asp Tyr
Thr Leu Phe Met
Thr Leu Met Phe
Thr Leu Tyr Asp
Thr Met Phe Ile
Thr Met Phe Leu
Thr Met Ile Phe
Thr Met Leu Phe
Thr Pro Phe Phe
Thr Val Glu Tyr
Thr Val Tyr Glu
Thr Tyr Asp Ile
Thr Tyr Asp Leu
Thr Tyr Glu Val
Thr Tyr Ile Asp
Thr Tyr Leu Asp
Thr Tyr Val Glu
Val Glu Thr Tyr
Val Glu Tyr Thr
Val His Gln Gln
Val Met Val Tyr
Val Met Tyr Val
Val Gln His Gln
Val Gln Gln His
Val Thr Glu Tyr
Val Thr Tyr Glu
Val Val Met Tyr
Val Val Tyr Met
Val Tyr Glu Thr
Val Tyr Met Val
Val Tyr Thr Glu
Val Tyr Val Met
Tyr Cys Ile Ile
Tyr Cys Ile Leu
Tyr Cys Leu Ile
Tyr Cys Leu Leu
Tyr Asp Ile Thr
Tyr Asp Leu Thr
Tyr Asp Thr Ile
Tyr Asp Thr Leu
Tyr Glu Ile Ser
Tyr Glu Leu Ser
Tyr Glu Ser Ile
Tyr Glu Ser Leu
Tyr Glu Thr Val
Tyr Glu Val Thr
Tyr Ile Cys Ile
Tyr Ile Cys Leu
Tyr Ile Asp Thr
Tyr Ile Glu Ser
Tyr Ile Ile Cys
Tyr Ile Leu Cys
Tyr Ile Ser Glu
Tyr Ile Thr Asp
Tyr Lys Asn Ser
Tyr Lys Ser Asn
Tyr Leu Cys Ile
Tyr Leu Cys Leu
Tyr Leu Asp Thr
Tyr Leu Glu Ser
Tyr Leu Ile Cys
Tyr Leu Leu Cys
Tyr Leu Ser Glu
Tyr Leu Thr Asp
Tyr Met Val Val
Tyr Asn Lys Ser
Tyr Asn Ser Lys
Tyr Ser Glu Ile
Tyr Ser Glu Leu
Tyr Ser Ile Glu
Tyr Ser Lys Asn
Tyr Ser Leu Glu
Tyr Ser Asn Lys
Tyr Thr Asp Ile
Tyr Thr Asp Leu
Tyr Thr Glu Val
Tyr Thr Ile Asp
Tyr Thr Leu Asp
Tyr Thr Val Glu
Tyr Val Glu Thr
Tyr Val Met Val
Tyr Val Thr Glu
Tyr Val Val Met
ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester
ent-6,9-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy - l)phenyl]amino]-4-pyrimidinyl]amino]benz
Flordipine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker
2-[2-butyl-4-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5-imidazo[4,5-c]pyridinyl]-N,N-dimethylacetamide
Tetrahydroasterriquinone
A member of the class of dihydroxy-1,4-benzoquinones that is asterriquinone in which the double bonds in both of the N-(3-methylbut-1-en-3-yl) groups have been reduced to single bonds.
(E)-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyloct-2-enamide
Ajugacumbin A Chlorohydrin
A diterpene lactone isolated from the whole plants of Ajuga ciliata.
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-(4-methoxyphenyl)urea
1,2-Dioctanoyl-sn-glycero-3-phosphoserine(1-)
A 3-sn-phosphatidyl-L-serine(1-) that is the conjugate base of 1,2-dioctanoyl-sn-glycero-3-phosphoserine, obtained by deprotonation of the phosphate OH group; major species at pH 7.3.
(3S,3S,4R,5S)-4-[fluoro(dimethyl)silyl]-5-(2-hydroxyethyl)-3-methyl-1-[[4-(2-oxo-1-piperidinyl)phenyl]methyl]-2-spiro[indole-3,2-oxolane]one
1-[1-[4-[(3-Oxo-5-phenyl-4-morpholinyl)methyl]-1-triazolyl]-3-phenylpropan-2-yl]-3-phenylurea
6-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxyheptanoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
(1s,2s,4as,5r,6s,8r,8as)-5-[(2r,3ar,5r,6as)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
2,9-dihydroxy-6,11-dimethyl-16-methylidene-17-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[13.2.1.0¹,¹².0³,¹¹.0⁶,¹⁰]octadecan-7-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,3r,4s,5r,9r,10r,13r)-3,10-dihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(1s,2s,3r,4r,7s,8z,12s,13s,14s,16s,17r)-12,14-bis(acetyloxy)-3,16-dihydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate
(1r,2r,5s,8r,10s,11r,12s)-2,9-bis(acetyloxy)-5,11-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-oxotricyclo[9.3.1.0³,⁸]pentadec-3-en-10-yl acetate
(1r,2s,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5s,6as)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
10-debenzoyal-2alpha-acetoxy-brevifoliol
{"Ingredient_id": "HBIN000099","Ingredient_name": "10-debenzoyal-2alpha-acetoxy-brevifoliol","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1O)C(C)(C)O)OC(=O)C)O)OC(=O)C)C)OC(=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26022","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
10-debenzoyl-2α-acetoxy-brevifoliol
{"Ingredient_id": "HBIN000100","Ingredient_name": "10-debenzoyl-2\u03b1-acetoxy-brevifoliol","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1O)C(C)(C)O)OC(=O)C)O)OC(=O)C)C)OC(=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5α,7β,10β,13α-tetrahydroxy-2α,9α,15-tri-acetoxy-11(15→1)-abeo-taxa-4(20),11-diene
{"Ingredient_id": "HBIN011388","Ingredient_name": "5\u03b1,7\u03b2,10\u03b2,13\u03b1-tetrahydroxy-2\u03b1,9\u03b1,15-tri-acetoxy-11(15\u21921)-abeo-taxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21145","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenostemmmoside b
{"Ingredient_id": "HBIN014697","Ingredient_name": "adenostemmmoside b","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "CC1(CCCC2(C1CCC34C2(C(CC(C3)C(=C)C4=O)O)O)C)C(=O)OC5C(C(C(C(O5)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23673","TCMSP_id": "NA","TCM_ID_id": "7160","PubChem_id": "NA","DrugBank_id": "NA"}